150 related articles for article (PubMed ID: 1003541)
1. Leukocyte migration inhibition by soluble extracts of MCF-7 tissue culture cell line derived from breast carcinoma.
McCoy JL; Jerome LF; Anderson C; Cannon GB; Alford TC; Connor RJ; Oldham RK; Herberman RB
J Natl Cancer Inst; 1976 Nov; 57(5):1045-9. PubMed ID: 1003541
[TBL] [Abstract][Full Text] [Related]
2. Leukocyte migration inhibition in patients with Ewing's sarcoma by 3-M potassium chloride extracts of fresh and tissue-cultured Ewing's sarcomas.
McCoy JL; Jerome LJ; Cannon GB; Pomeroy TC; Connor RJ; Oldham RK; Weese JL; Herberman RB
J Natl Cancer Inst; 1977 Oct; 59(4):1119-25. PubMed ID: 903991
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of leukocyte migration by tumor-associated antigens in soluble extracts of human malignant melanoma.
McCoy JL; Jerome LF; Dean JH; Perlin E; Oldham RK; Char DH; Cohen MH; Felix EL; Herberman RB
J Natl Cancer Inst; 1975 Jul; 55(1):19-23. PubMed ID: 1057654
[TBL] [Abstract][Full Text] [Related]
4. Immunologic relationship between breast carcinoma and benign breast disease as detected by the leukocyte migration inhibition assay.
Cannon GB; McCoy JL; Jerome LJ; Reddick R; Alford C; Tinley V; Herberman RB
J Natl Cancer Inst; 1978 Nov; 61(5):1181-6. PubMed ID: 280705
[TBL] [Abstract][Full Text] [Related]
5. Reactivity of lung cancer patients in leukocyte migration inhibition assays to 3-M potassium chloride extracts of fresh tumor and tissue-cultured cells derived from lung cancer.
McCoy JL; Jerome LF; Cannon GB; Weese JL; Herberman RB
J Natl Cancer Inst; 1977 Nov; 59(5):1413-8. PubMed ID: 909101
[No Abstract] [Full Text] [Related]
6. Inhibition of leukocyte migration by human breast-cancer-associated antigens.
Kadish AS; Marcus DM; Bloom BR
Int J Cancer; 1976 Nov; 18(5):581-6. PubMed ID: 62721
[TBL] [Abstract][Full Text] [Related]
7. Cell-mediated immunity in patients with renal cell carcinoma as measured by leukocyte migration inhibition test.
Wright GL; Schellhammer PF; Rosato FE; Faulconer RJ
Urology; 1978 Nov; 12(5):525-31. PubMed ID: 726170
[TBL] [Abstract][Full Text] [Related]
8. Use of the leukocyte migration inhibition assay to evaluate antigenic differences in human breast cancers and melanomas.
Cannon B; McCoy JL; Connor RJ; Jerome L; Keys L; Dean HH; Herberman RB
J Natl Cancer Inst; 1978 May; 60(5):969-78. PubMed ID: 76682
[TBL] [Abstract][Full Text] [Related]
9. Leukocyte migration inhibition among breast cancer patients in response to various oncogenic viruses.
Fukuda M; Wanebo HJ; Tsuei L; Ashikari R; Sarkar NH
J Natl Cancer Inst; 1980 Mar; 64(3):431-7. PubMed ID: 6243720
[TBL] [Abstract][Full Text] [Related]
10. Production of melanoma-associated antigen(s) by a defined malignant melanoma cell strain grown in chemically defined medium.
Chee DO; Boddie AW; Roth JA; Holmes EC; Morton DL
Cancer Res; 1976 Apr; 36(4):1503-9. PubMed ID: 1260767
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of leukocyte migration by soluble tumor extracts in human malignant melanoma.
Lapińska M; Jassem J; Kondrat W; Jaśkiewicz J
Neoplasma; 1980; 27(1):37-42. PubMed ID: 6154899
[TBL] [Abstract][Full Text] [Related]
12. Detection of cell-mediated immune reactivity of breast cancer patients by the leukocyte adherence inhibition response to MCF-7 extracts.
Rudczynski AB; Dyer CA; Mortensen RF
Cancer Res; 1978 Nov; 38(11 Pt 1):3590-4. PubMed ID: 81103
[No Abstract] [Full Text] [Related]
13. Cell-mediated immune responses of breast cancer patients to autologous tumor-associated antigens.
Dean JH; McCoy JL; Cannon GB; Leonard CM; Perlin E; Kreutner A; Oldham RK; Herberman RB
J Natl Cancer Inst; 1977 Mar; 58(3):549-55. PubMed ID: 138751
[TBL] [Abstract][Full Text] [Related]
14. Detection of human tumor-associated antigens by the leukocyte migration in agarose assay.
Boddie AW; Urist MM; Chee DO; Holmes C; Morton DL
Int J Cancer; 1976 Aug; 18(2):161-7. PubMed ID: 60286
[TBL] [Abstract][Full Text] [Related]
15. Leukocyte adherence inhibition: tumor specificity of cellular and serum-blocking reactions in human melanoma, breast cancer, and colorectal cancer.
Halliday WJ; Koppi TA; Khan JM; Davis NC
J Natl Cancer Inst; 1980 Aug; 65(2):327-35. PubMed ID: 6157045
[TBL] [Abstract][Full Text] [Related]
16. Cell-mediated immune reactivity of Sinclair melanoma-bearing swine to 3 M KCl extracts of swine and human melanoma.
Hook RR; Hamby CV; Millikan LE; Berkelhammer J; Stills HF; Oxenhandler RW
Int J Cancer; 1983 May; 31(5):633-7. PubMed ID: 6852980
[TBL] [Abstract][Full Text] [Related]
17. Cell-mediated immunity to mouse mammary tumor virus antigens by patients with hyperplastic benign breast disease.
Cannon GB; Barsky SH; Alford TC; Jerome LF; Tinley V; McCoy JL; Dean JH
J Natl Cancer Inst; 1982 Jun; 68(6):935-43. PubMed ID: 6283226
[TBL] [Abstract][Full Text] [Related]
18. Checking of carcinoma patients with the leukocyte migration technique (LMT) under agarose.
Emmrich F; Ambrosius H
Neoplasma; 1978; 25(4):483-91. PubMed ID: 80756
[TBL] [Abstract][Full Text] [Related]
19. Leukocyte migration inhibition in relation to nuclear pleomorphism and lymphoid infiltration in breast cancer.
Egami H; Sakamoto K; Kimura M; Nishimura R; Akagi M
Jpn J Clin Oncol; 1985 Jun; 15(2):393-401. PubMed ID: 2410639
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of leukocyte migration in agarose by KCl extracts of human melanoma cell line grown in serum-free medium.
Boddie AW; Urist MM; Chee DO; Holmes EC; Morton DL
Int J Cancer; 1975 Dec; 16(6):1035-41. PubMed ID: 1201872
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
